US Organ Preservation Market: Industry Analysis and Forecast (2024-2030)

  • The US Organ Preservation Market size was valued at USD 69.3 Mn. in 2023 and the total US Organ Preservation revenue is expected to grow at a CAGR of 3.9% from 2024 to 2030, reaching nearly USD 90.58 Mn.

  • Format : PDF | Report ID : SMR_1642

US Organ Preservation Market Overview

Organ preservation involves removing, storing, and transporting healthy organs from donors to recipients. Commonly transplanted organs include kidneys, heart, lungs, and liver. Preservation methods like static cold storage, hypothermic machine perfusion, and normothermic machine perfusion maintain organ temperature and oxygen levels. Special solutions help sustain organ quality. The US Organ Preservation market is fueled by the growing prevalence of chronic diseases, an aging population requiring transplants, government initiatives promoting organ donation, and advancements like normothermic machine perfusion, fostering positive market trends.


The comprehensive report serves as a detailed US Organ Preservation Market analysis. STELLAR has precisely examined the industry's evolution, spotlighting significant trends, groundbreaking innovations, and the driving forces that mold its trajectory. Delving deep into the present landscape, the report dissects the US Organ Preservation Market. It accurately outlines the market's current dimensions, growth patterns, size, and the nuanced trends that use significant influence. Additionally, it keenly identifies the pivotal factors driving market growth and sheds light on growing opportunities.

US Organ Preservation Market


US Organ Preservation Market Dynamics:

Increasing Prevalence of Chronic Diseases to Drive the US Organ Preservation Market

In the US, 6 in 10 adults suffer from chronic diseases, with 4 in 10 having two or more, as per the CDC. Over 106,000 individuals await organ transplants. Organ transplant costs range from USD 100,000 to over USD 1 million. The increasing US Organ Preservation Market prompts increased investment in research and development, fostering innovation for more effective preservation techniques, potentially reducing transplant wait times and enhancing patient outcomes. Normothermic perfusion, particularly, improves organ viability, improving transplant success rates and saving lives. Studies demonstrate its superior viability compared to traditional cold storage.

US Organ Preservation Market1

The US organ preservation market rising demand for organs raises ethical concerns, including potential exploitation and fair allocation. Organ transplantation's high cost, exacerbated by preservation technologies, burdens healthcare systems and patients. Limited donor availability intensifies the gap between patients needing transplants and available organs, necessitating increased public awareness and donation initiatives for equitable access.


The growing chronic disease prevalence complicates the US organ preservation market, driving growth and innovation but also posing ethical concerns, and financial burdens, and highlighting limited donor availability. Addressing these challenges and promoting responsible practices are crucial for ensuring equitable access to life-saving organ transplants.


US Organ Preservation Market Segment Analysis

Based on the Organ Donation Type, the Deceased Organ Donation segment held the largest market share of about 30% in the US Organ Preservation Market in 2023. According to the STELLAR analysis, the segment is expected to grow at a CAGR of 3.9% during the forecast period. It stands out as the dominant segment within the US Organ Preservation Market thanks to its rapid technological advancement and growing adoption of smart devices with data connectivity and integration.

US Organ Preservation Market2

Deceased organ donation, addresses the rising demand for organs. The US Organ Preservation Market blooms on preservation solutions thanks to increased donations, driving growth in storage, logistics, and perfusion technologies. Advancements in hypothermic storage and organ perfusion, driven by donations, improve organ viability. Public awareness campaigns further amplify potential donors, augmenting organ availability.


Additionally, Ethical concerns, including informed consent and potential exploitation, impede deceased organ donation, restricting available organs. Logistical challenges, such as procurement delays, impend US Organ Preservation Market growth and contribute to organ wastage. Medical contraindications limit eligible donors, impacting organ availability. Socioeconomic disparities in healthcare access pose ethical and logistical challenges for organ preservation.


The deceased organ donation sector is key in the US organ preservation market, offering growth opportunities and technological advances. Despite benefits, ethical, logistical, and social challenges persist. Innovations like normothermic machine perfusion enhance viability. Public education debunking myths is vital for donor registration. Collaborative efforts are crucial to streamline logistics and ensure equitable transplantation access.

US Organ Preservation Market Scope

Market Size in 2023

USD 69.3 Million

Market Size in 2030

USD 90.58 Million

CAGR (2024-2030)

3.9 %

Historic Data


Base Year


Forecast Period


Segment Scope

By Preservation Solution

  • UW Solution
  • Custodiol HTK
  • Perfadex

By Organ Donation Type

  • Living Organ Donation
  • Deceased Organ Donation

By Technique

  • Static Cold Storage Technique
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion

By Organ Type

  • Kidney
  • Liver
  • Lung
  • Heart

By End User

  • Hospitals and Clinics
  • Organ Banks


Leading Key Players in the US Organ Preservation Market

  • Xvivo Perfusion AB
  • Organ Recovery Systems
  • Waters Medical Systems
  • TransMedics, Inc.
  • Paragonix Technologies, Inc.
  • Essential Pharmaceuticals, LLC
  • OrganOx Limited
  • Bridge to Life Ltd.
  • 21st Century Medicine, Inc.

Frequently Asked Questions

Rising Demand for Dietary Supplements is expected to be the major driver for the US Organ Preservation market.

1.    US Organ Preservation Market Executive Summary
1.1 Study Assumption and Market Definition
1.2 Scope of the Study
1.3 Emerging Technologies
1.4 Market Projections
1.5 Strategic Recommendations
2.    US Organ Preservation Market Trends
2.1 Market Consolidation
2.2 Adoption of Advanced Technologies
2.3 Pricing and Reimbursement Trends
3.    US Organ Preservation Market: Dynamics
3.1.1 Market Driver
3.1.2 Market Restraints
3.1.3 Market Opportunities
3.1.4 Market Challenges

3.2 PORTER’s Five Forces Analysis
3.3 PESTLE Analysis
3.4 Regulatory Landscape 
3.5 Analysis of Government Schemes and Initiatives for the US Organ Preservation Industry
3.6 The Pandemic and Redefining of The US Organ Preservation Industry Landscape
4.    US Organ Preservation Market: Market Size and Forecast by Segmentation (Value) (2023-2030)
4.1 US Organ Preservation Market Size and Forecast, by Preservation Solution (2023-2030)
4.1.1 UW Solution
4.1.2 Custodiol HTK
4.1.3 Perfadex

4.2 US Organ Preservation Market Size and Forecast, by Organ Donation Type (2023-2030)
4.2.1 Living Organ Donation
4.2.2 Deceased Organ Donation

4.3 US Organ Preservation Market Size and Forecast, by Technique (2023-2030)
4.3.1 Static Cold Storage Technique
4.3.2 Hypothermic Machine Perfusion
4.3.3 Normothermic Machine Perfusion

4.4 US Organ Preservation Market Size and Forecast, by Organ Type (2023-2030)
4.4.1 Kidney
4.4.2 Liver
4.4.3 Lung
4.4.4 Heart

4.5 US Organ Preservation Market Size and Forecast, By End User (2023-2030)
4.5.1 Hospitals and Clinics
4.5.2 Organ Banks

5.    US Organ Preservation Market: Competitive Landscape
5.1 STELLAR Competition Matrix
5.2 Competitive Landscape
5.3 Key Players Benchmarking
5.3.1 Company Name
5.3.2 Service Segment
5.3.3 End-user Segment 
5.3.4 Revenue (2023)
5.3.5 Company Locations

5.4 Leading US Organ Preservation Companies, by market capitalization
5.5 Market Structure
5.5.1 Market Leaders 
5.5.2 Market Followers
5.5.3 Emerging Players

5.6 Mergers and Acquisitions Details
6.    Company Profile: Key Players
6.1 DSM Nutritional Products
6.1.1 Company Overview
6.1.2 Business Portfolio
6.1.3 Financial Overview
6.1.4 SWOT Analysis
6.1.5 Strategic Analysis
6.1.6 Scale of Operation (small, medium, and large)
6.1.7 Details on Partnership
6.1.8 Regulatory Accreditations and Certifications Received by Them
6.1.9 Awards Received by the Firm
6.1.10  Recent Developments

6.2 DSM Nutritional Products
6.3 Croda International plc
6.4 Omega Protein Corporation (now part of Cooke Inc.)
6.5 GC Rieber Oils
6.6 Colpex International
6.7 TripleNine Group
6.8 Corbion N.V.
6.9 Archer Daniels Midland Company (ADM)
6.10 Copeinca ASA
6.11 Epax Norway AS (A Subsidiary of FMC Corporation)
7.    Key Findings
8.    Industry Recommendations
9.    Terms and Glossary
10.    US Organ Preservation Market: Research Methodology

Enquiry Before Buy

Request Sample PDF